WuXi AppTec
Latest statistics and disclosures from WuXi AppTec's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001832424
Tip: Access up to 7 years of quarterly data
Positions held by WuXi AppTec consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for WuXi AppTec
WuXi AppTec holds 5 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Lyell Immunopharma (LYEL) | 41.2 | $16M | 8.2M | 1.94 |
|
|
Ambrx Biopharma | 36.9 | $14M | 1.0M | 14.24 |
|
|
Adagene Ads (ADAG) | 21.2 | $8.2M | 4.2M | 1.93 |
|
|
Purple Biotech Sponsored Ads (PPBT) | 0.4 | $151k | 194k | 0.78 |
|
|
Castle Biosciences (CSTL) | 0.4 | $143k | 6.6k | 21.58 |
|
Past Filings by WuXi AppTec
SEC 13F filings are viewable for WuXi AppTec going back to 2023
- WuXi AppTec 2023 Q4 filed Feb. 6, 2024